Screening

Pop Quiz: Risk Factors for Fracture in Men

Current Consultant Issue

Previous Issues

Early View

Research Summaries

Research Summary

Research Summary

Measurement-Based Care Speeds Depression Response, Remission in Randomized Trial

05/06/2026

Kate Young

A randomized clinical trial in Pakistan evaluated whether structured, measurement-based care could accelerate antidepressant response and remission in adults with major depressive disorder compared with...

05/06/2026

FDA Approval

FDA Approval

FDA Approves Vepdegestrant (Veppanu) for ESR1-Mutated, ER-Positive, HER2-Negative Advanced Breast Cancer

05/04/2026

Anthony Calabro, MA

On May 1, the FDA approved vepdegestrant (Veppanu), a heterobifunctional protein degrader, for adults with estrogen receptor–positive, human epidermal growth factor receptor 2–negative, ESR1-mutated...

05/04/2026

Research Summary

Research Summary

Habit-Based Lifestyle Intervention Improves Long-Term Metabolic Syndrome Remission in US Adults

05/04/2026

Kate Young

A randomized clinical trial evaluated whether a 6-month habit-focused lifestyle program could improve sustained remission of metabolic syndrome at 24 months compared with standard education and activity...

05/04/2026

FDA Alert

older patient and younger individual holding hands

FDA Alert

FDA Approves Auvelity for Agitation in Alzheimer Disease Dementia

05/01/2026

Anthony Calabro, MA

The FDA has approved dextromethorphan-bupropion extended-release tablets for agitation associated with Alzheimer disease dementia, offering clinicians a non-antipsychotic treatment option supported by...

05/01/2026

FDA Approval

FDA Approval

Lumateperone (Caplyta) Gains FDA Approval for Relapse Prevention in Schizophrenia

04/30/2026

Anthony Calabro, MA

The FDA has approved a supplemental indication for lumateperone to reduce relapse risk in adults with schizophrenia based on phase 3 randomized withdrawal data.

04/30/2026

Trending Articles

Disease State Pillar

Disease State Pillar

HIV Management: A Practical Guide for Primary Care

12/09/2025

With modern antiretroviral therapy (ART), human immunodeficiency virus (HIV) is a chronic, manageable condition—but outcomes hinge on rapid treatment start, durable viral suppression, and proactive primary...

12/09/2025

Disease State Pillar

Disease State Pillar

Chronic Obstructive Pulmonary Disease: A Comprehensive Guide for Primary Care

11/05/2025

What is COPD? Chronic obstructive pulmonary disease (COPD) is a progressive, preventable condition marked by airflow limitation and respiratory symptoms such as dyspnea, chronic cough, and sputum...

11/05/2025

Disease State Pillar

Disease State Pillar

Agitation in Alzheimer Disease: A Comprehensive Guide for Primary Care

09/08/2025

Agitation is a common and challenging behavioral symptom in dementia that primary care providers frequently encounter. Characterized by increased motor activity, restlessness, verbal or physical aggression,...

09/08/2025

Slideshow

Slideshow

Consultant360’s Summer Playlist: Expert Perspectives on Emerging Clinical Issues

09/15/2025

This summer, Consultant360 brought you thought-provoking conversations with leading clinicians on some of the most pressing issues in patient care—from the latest Advisory Committee on Immunization...

09/15/2025

Meeting Coverage

Meeting Coverage

What Clinicians Need to Know About ACIP’s June 2025 Meeting

09/26/2025

Key Highlights Clesrovimab approved for infants under 8 months to prevent respiratory syncytial virus during their first season, and added to the Vaccines for Children program for free access. FluMist...

09/26/2025